These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38514020)

  • 1. Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review.
    Patel D; Sethi N; Patel P; Shah S; Patel K
    Eur J Pharm Biopharm; 2024 May; 198():114267. PubMed ID: 38514020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
    Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
    Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
    Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review.
    Dong J; Yuan L; Hu C; Cheng X; Qin JJ
    Pharmacol Ther; 2023 Sep; 249():108488. PubMed ID: 37442207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
    Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
    J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer.
    Halder J; Pradhan D; Kar B; Ghosh G; Rath G
    Nanomedicine; 2022 Feb; 40():102494. PubMed ID: 34775061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
    Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
    Binkhathlan Z; Lavasanifar A
    Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
    Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
    Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric Drug-Delivery Systems: Role in P-gp Efflux System Inhibition.
    Gupta P; Garg T; Tanmay M; Arora S
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):247-75. PubMed ID: 26080810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions.
    Cao Y; Shi Y; Cai Y; Hong Z; Chai Y
    Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mahanimbine isolated from Murraya koenigii inhibits P-glycoprotein involved in lung cancer chemoresistance.
    Mondal P; Natesh J; Abdul Salam AA; Meeran SM
    Bioorg Chem; 2022 Dec; 129():106170. PubMed ID: 36174443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.